|
Active Ingredient
|
VILDAGLIPTIN | METFORMIN
|
|
Therapeutic Class
|
DIPEPTIDYL PEPTIDASE INHIBITORS
|
|
Indications
|
Type 2 diabetes mellitus as monotherapy (if metformin inappropriate), or in combination with other antidiabetic drugs (including insulin) if existing treatment fails to achieve adequate glycaemic cont More ...
|
|
Caution
|
Asthenia, dizziness, headache, nausea;, peripheral oedema, tremor.
|
|
Dose Range
|
1 tablet twice daily based on patient’s current metformin dose.
|
|
Drug Interactions
|
|
|
Pregnancy
|
|
|
Breast Feeding
|
|
